EpCAM is highly expressed on certain tumors and on tumor exosomes, which may induce cross-presentation of tumor-derived neoantigen (i.e., in exosomes or debris), resulting in better priming of tumor neoantigen-specific T cells (52). Here, EPCAM is linked to neoplasm.